Research on Severe Asthma

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Sep 2, 2019

Keywords

ClinConnect Summary

This clinical trial, called RAMSES, is looking into severe asthma in adult patients across France. The goal is to better understand the characteristics of people suffering from this serious condition and how they respond to advanced treatments. These treatments include high doses of medication and specialized procedures, which are used when asthma is particularly difficult to manage. By gathering this information, the researchers hope to improve care for patients with severe asthma and meet requirements set by health authorities for new treatments.

To participate in this trial, you must have severe asthma, which means you are likely taking high doses of medication or have been on long-term steroid treatments. You should also be receiving care from a participating center. If you decide to join, you will be asked to share your health information to help researchers build a comprehensive picture of asthma treatment and outcomes. Your participation is voluntary, and your data will be handled confidentially. This study could also contribute to broader efforts across Europe to improve asthma care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Patient with severe asthma : Meeting the definition of ATS-ERS: which requires a combination of high dose CSI and B2LDA.
• Or receiving level 5 support (initiating treatment or already treated) :
• • Long-term oral corticosteroids (\> 6 months in the year prior to inclusion)
• • And / or monoclonal antibody
• • And / or bronchial thermoplasty
• • And / or other complex costs corresponding to the level 5 treatments
• • Consultant or hospitalized in one of the centers participating in RAMSES study
• Exclusion Criteria:
• • Patient does not accept the recording of his data in the cohort
• • Patient not benefiting from health insurance coverage
• • Patient under curatorship or tutorship